Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
03/2010
03/25/2010US20100076066 Novel IDO Inhibitors and Methods of Use Thereof
03/25/2010US20100076051 Isoindolinone kinase inhibitors
03/25/2010US20100076036 Heterocyclyl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders
03/25/2010US20100076001 Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer
03/25/2010US20100075982 Pyridinone Derivative For The Treatment of Premature Ejaculation
03/25/2010US20100075967 Pyrimidine derivatives for treatment of hyperproliferative disorders
03/25/2010US20100075960 Benzimidazole thiophene compounds
03/25/2010US20100075951 Heteroaryls and uses thereof
03/25/2010US20100075941 Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof
03/25/2010US20100075047 Anthrapyridone dyes and their preparation and use
03/25/2010US20100074973 Thioxanthene modulators of dopamine d2 receptors
03/25/2010US20100071769 Fluorene derivatives and organic electronic device using the same
03/25/2010CA2770302A1 Small molecule compounds for stem cell differentiation
03/25/2010CA2737738A1 Heterocyclic carboxamide compounds
03/25/2010CA2737199A1 Novel compounds as cannabinoid receptor ligands
03/25/2010CA2735931A1 Amide compounds useful in therapy
03/25/2010CA2734363A1 Substituted pyrrolidine-2-carboxamides
03/24/2010EP2166003A1 Excitatory amino acid receptor antagonists
03/24/2010EP2164845A1 Novel 4-heteroaryl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology
03/24/2010EP2164843A1 Pyridazinone derivates
03/24/2010EP1644357B9 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
03/24/2010EP1389110B1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
03/24/2010CN101679397A Quinolone and tetrahydroquinoline and related compounds having nos inhibitory activity
03/24/2010CN101679396A triazolyl aminopyrimidine compounds
03/24/2010CN101679395A triazolyl aminopyrimidine compounds
03/24/2010CN101679394A oxime ester photoinitiators
03/24/2010CN101679393A 荧光材料 Fluorescent material
03/24/2010CN101679392A Quinolone compound and pharmaceutical composition
03/24/2010CN101679388A Novel 4-heteroaryl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology
03/24/2010CN101679377A Heterocyclic hydrazide compound and pesticidal use of the same
03/24/2010CN101679375A 8-oxy-quinoline derivatives as bradykinin b2 receptor modulators
03/24/2010CN101679371A Substituted pyrimidines as adenosine receptor antagonists
03/24/2010CN101679365A Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application
03/24/2010CN101679364A heteroarylamide pyrimidone compounds
03/24/2010CN101679361A Certain substituted amides, method of making, and method of use thereof
03/24/2010CN101679357A Substituted heterocyclic derivatives and their pharmaceutical use and compositions
03/24/2010CN101679355A benzimidazole cannabinoid agonists
03/24/2010CN101679354A Novel triazinedione derivatives as GABAB receptor modulators
03/24/2010CN101679345A Novel microbiocides
03/24/2010CN101679318A Development of molecular imaging probes for carbonic anhydrase-IX using click chemistry
03/24/2010CN101679306A Heteroarylamide pyrimidone derivatives
03/24/2010CN101679287A nicotinic acetylcholine receptor modulators
03/24/2010CN101679279A Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists
03/24/2010CN101679258A 4 -pi peridinylurea compounds as soluble epoxide hydrolase inhibitors
03/24/2010CN101679255A Piperidinones useful in the treatment of inflammation
03/24/2010CN101676271A Tetracycline derivatives containing unsaturated heterocyclic amine
03/24/2010CN100595195C Preparation method and application of isoquinoline componds and salts thereof
03/23/2010US7683185 6-(4-Dimethylamino-phenylsulfanyl)-hexa-2,4-dienoic acid methyl ester; stimulating hematopoietic cells ex vivo
03/23/2010US7683173 Biphenyl compounds useful as muscarinic receptor antagonists
03/23/2010US7683094 2-(2-((2R)-2-heptylaminomethyl-5-oxopyrrolidin-1-yl)ethylthio)-1,3-thiazole-4-carboxylic acid; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder
03/23/2010US7683081 arthritis, allergic contact dermatitis, psoriasis, asthma, rheumatoid arthritis, or stroke; using producing coronary vasodilation without significant peripheral vasodilation
03/23/2010US7683078 Neuronal disorders, autoimmune diseases, cancer, cardiovascular diseases; such as 4-Chloro-N-{5-[1-(4-trifluoromethyl-benzyl)-piperidin-3-ylsulfamoyl]-25 thiophen-2-ylmethyl)-benzamide
03/23/2010US7683069 3-substituted-4-pyrimidone derivatives
03/23/2010US7683068 Emesis, urinary incontinence, depression, and anxiety; substance P inhibitors; 5-{1-[3,5-bis(Trifluoromethyl)phenyl]ethoxy}-4-(4-fluorophenyl)octahydro-1H-isoindole
03/23/2010US7683067 3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (GSK-3)
03/23/2010US7683059 Triazole compounds and uses related thereto
03/23/2010CA2354387C Substituted pyridine herbicides
03/18/2010WO2010030967A1 4-aryloxyquinolin-2(1h)-ones as mtor kinase and pi3 kinase inhibitors, for use as anti-cancer agents
03/18/2010WO2010030592A1 Compounds for the treatment of hepatitis c
03/18/2010WO2010029986A1 Glucocorticoid receptor agonist comprising novel 1,2,3,4-tetrahydroquinoxaline derivative containing phenyl group having sulfonic acid ester structure introduced therein as substituent
03/18/2010WO2010029379A1 Compounds for inhibiting semicarbazide-sensitive amine oxidase (ssao) / vascular adhesion protein-1 (vap-1) and uses thereof for treatment and prevention of diseases
03/18/2010WO2010029299A1 Pyrimidinone derivaties for use as medicaments
03/18/2010WO2010028862A1 Pyrrolidin-2-ones as hdm2 ligands
03/18/2010WO2010007382A8 Benzazepine derivatives and their use as hstamine h3 antagonists
03/18/2010US20100069440 Pyridine non-classical cannabinoid compounds and related methods of use
03/18/2010US20100069417 Novel phenyl(4-phenylpyrimidin-2-yl)amine derivatives, their preparation, as medicaments, pharmaceutical compositions and in particular as ikk inhibitors
03/18/2010US20100069379 Bicyclic androgen and progesterone receptor modulator compounds and methods
03/18/2010US20100069378 Substituted indanyl sulfonamide compounds, their preparation and use as medicaments
03/18/2010CA2736988A1 Compounds for the treatment of hepatitis c
03/18/2010CA2736970A1 Pyrimidinone derivatives for use as medicaments
03/18/2010CA2736295A1 Pyrrolidin-2-ones as hdm2 ligands
03/18/2010CA2735417A1 Glucocorticoid receptor agonist comprising novel 1,2,3,4-tetrahydroquinoxaline derivatives containing phenyl group having sulfonic acid ester structure introduced therein as substituent
03/17/2010EP2163553A1 Arene connected polyamine macroring derivatives, preparation methods and pharmaceutical uses thereof
03/17/2010EP2162433A2 4' substituted compounds having 5-ht6 receptor affinity
03/17/2010EP1713822B1 Hcv ns-3 serine protease inhibitors
03/17/2010EP1654257B1 Aminopyrones and their use as atm inhibitors
03/17/2010EP1620411B1 Inhibitors of akt activity
03/17/2010EP1513814B1 Novel piperidine compound
03/17/2010EP1423387B1 Photochromic bis-naphthopyran compounds and methods for their manufacture
03/17/2010CN101675042A Novel 2-heteroaryl substituted benzothiophenes and benzofuranes 709
03/17/2010CN101671331A Lipoyl vildagliptin as well as preparation method and application thereof
03/17/2010CN101671310A Compounds and compositions useful as cathepsin s inhibitors
03/17/2010CN101671307A 杂环天冬氨酰蛋白酶抑制剂 Heterocyclic aspartyl protease inhibitors
03/17/2010CN101671291A Novel organic electroluminescent compounds and organic electroluminescent device using the same
03/17/2010CN101669952A Pyridazine derivatives and their use as therapeutic agents
03/16/2010US7678917 5-Chloro-thiophene-2-carboxylic acid {(1S,2S,4R)-4-[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-2-hydroxy-cyclopentyl}-amide; anticoagulant, antiinflammatory agent; thrombosis, peripheral arterial occlusive disease, stroke, arteriosclerosis, bypass grafting
03/16/2010US7678831 2-{2-[3-(4-chlorophenyl)acryloyl]-4-methylphenoxy}-4-phenylbutanoic acid; Peroxisome Proliferator Activated Receptors (PPAR); diabetes, dyslipidemia and/or atherosclerosis
03/16/2010US7678813 8a-Benzyl-2-(4-methoxyphenyl)-1,3,4,7,8,8a-hexahydro-2H-isoquinolin-6-one; psychotic major depression, schizoaffective disorder, Alzheimer's Disease and cocaine addiction
03/16/2010US7678812 Aminotetralin-derived urea modulators of vanilloid VR1 receptor
03/16/2010US7678804 Pyrimidine derivatives for treatment of hyperproliferative disorders
03/16/2010US7678802 Voltage gated sodium and calcium channel inhibitors
03/16/2010US7678798 5-({4-[(3S)-4-(5-bromo-2,3-dihydro-1H-inden-1-yl)-3-methylpiperazin-1-yl]-4-methylpiperidin-1-yl}carbonyl)-4,6-dimethylpyrimidine; inflammatory diseases, immune diseases and viral infections; HIV
03/16/2010US7678790 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, antithrombotic agents
03/16/2010US7678474 Imidazole derivatives and organic electronic device using the same
03/16/2010CA2386980C Benzodiazepine derivatives for use in acute or chronic neurological disorders
03/11/2010WO2010027875A2 Compounds that modulate intracellular calcium
03/11/2010WO2010027770A1 Crystalline forms of sufentanil citrate
03/11/2010WO2010026771A1 Nitrogenated heterocyclic compound and salt thereof, and bactericidal agent for agricultural or horticultural applications
03/11/2010WO2010026365A1 N-myristoyl transferase inhibitors
03/11/2010WO2010026212A1 Novel inhibitors